Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Merville

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Journal of the American Society of Nephrology : JASN|June 7, 2015
Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft SurvivalGwendaline Guidicelli, Florent Guerville, Sébastien Lepreux, et al.
Transplantation|October 8, 2014
Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocationJonathan Visentin, Gwendaline Guidicelli, Thomas Bachelet, et al.
Frontiers in Immunology|July 17, 2020
Distribution of <i>de novo</i> Donor-Specific Antibody Subclasses Quantified by Mass Spectrometry: High IgG3 Proportion Is Associated With Antibody-Mediated Rejection Occurrence and SeverityVincent Pernin, Anais Beyze, Ilan Szwarc, et al.
Journal of the American Society of Nephrology : JASN|August 29, 2009
Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantationLionel Couzi, Yann Levaillant, Abdellah Jamai, et al.
Transplantation|November 15, 2012
Factors predictive of medication nonadherence after renal transplantation: a French observational studyLionel Couzi, Bruno Moulin, Marie-Pascale Morin, et al.
Transplantation|August 12, 2015
Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney TransplantationThomas Bachelet, Charlie Martinez, Arnaud Del Bello, et al.
Trials|May 1, 2023
Evaluation of the efficacy of HEMO<sub>2</sub>life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trialYannick Le Meur, Emmanuel Nowak, Benoit Barrou, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 11, 2018
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donorFlavio Vincenti, Klemens Budde, Pierre Merville, et al.
European Radiology|May 17, 2012
Quantitative elastography of renal transplants using supersonic shear imaging: a pilot studyNicolas Grenier, Séverine Poulain, Sébastien Lepreux, et al.
Kidney International Reports|August 11, 2020
A Randomized Prospective Study Comparing Anti-T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant PatientsNassim Kamar, Benoit Lepage, Lionel Couzi, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Journal of the American Society of Nephrology : JASN|June 7, 2015
Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft SurvivalGwendaline Guidicelli, Florent Guerville, Sébastien Lepreux, et al.
Transplantation|October 8, 2014
Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocationJonathan Visentin, Gwendaline Guidicelli, Thomas Bachelet, et al.
Frontiers in Immunology|July 17, 2020
Distribution of <i>de novo</i> Donor-Specific Antibody Subclasses Quantified by Mass Spectrometry: High IgG3 Proportion Is Associated With Antibody-Mediated Rejection Occurrence and SeverityVincent Pernin, Anais Beyze, Ilan Szwarc, et al.
Journal of the American Society of Nephrology : JASN|August 29, 2009
Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantationLionel Couzi, Yann Levaillant, Abdellah Jamai, et al.
Transplantation|November 15, 2012
Factors predictive of medication nonadherence after renal transplantation: a French observational studyLionel Couzi, Bruno Moulin, Marie-Pascale Morin, et al.
Transplantation|August 12, 2015
Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney TransplantationThomas Bachelet, Charlie Martinez, Arnaud Del Bello, et al.
Trials|May 1, 2023
Evaluation of the efficacy of HEMO<sub>2</sub>life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trialYannick Le Meur, Emmanuel Nowak, Benoit Barrou, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 11, 2018
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donorFlavio Vincenti, Klemens Budde, Pierre Merville, et al.
European Radiology|May 17, 2012
Quantitative elastography of renal transplants using supersonic shear imaging: a pilot studyNicolas Grenier, Séverine Poulain, Sébastien Lepreux, et al.
Kidney International Reports|August 11, 2020
A Randomized Prospective Study Comparing Anti-T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant PatientsNassim Kamar, Benoit Lepage, Lionel Couzi, et al.
Pageof 13